Hepatitis C virus infection and heart diseases: a multicenter study in Japan

A Matsumori1, N Ohashi, K Hasegawa

  • 1Kyoto University, Japan.

Insights

Hepatitis C virus (HCV) infection is linked to heart conditions like hypertrophic and dilated cardiomyopathy. This study found a higher prevalence of HCV antibodies in patients with these cardiomyopathies compared to blood donors, suggesting HCV as a cause of heart disease.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Virology

Background:

  • Idiopathic cardiomyopathies represent a significant clinical challenge.
  • The potential role of viral infections, particularly hepatitis C virus (HCV), in the pathogenesis of cardiomyopathies requires further investigation.

Purpose of the Study:

  • To investigate the association between hepatitis C virus (HCV) infection and the development of hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM).
  • To determine the prevalence of HCV infection in patients diagnosed with cardiomyopathies in Japan.

Main Methods:

  • A collaborative research project involving 19 medical institutions in Japan.
  • Questionnaires were distributed to patients with idiopathic cardiomyopathies.
  • Hepatitis C virus antibody testing was performed on patient samples.
  • Prevalence data were compared with those of volunteer blood donors and patients seeking care in academic hospitals.

Main Results:

  • HCV antibodies were detected in 10.6% of HCM patients and 6.3% of DCM patients, significantly higher than the 2.4% in blood donors (p<0.0001).
  • The prevalence of HCV antibodies was significantly higher in HCM patients compared to DCM patients (p<0.01).
  • Overall, 5.4% of patients seeking care in academic hospitals tested positive for HCV antibodies, with arrhythmias being the most common cardiac abnormality.

Conclusions:

  • Hepatitis C virus infection is a significant contributing factor to various unexplained heart diseases, including hypertrophic and dilated cardiomyopathies.
  • These findings underscore the importance of screening for HCV in patients presenting with cardiomyopathies, especially in regions with high HCV prevalence.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...